[{"indications": "Indications\u00a0asthma and other conditions associated\r\nwith reversible airways obstruction; premature labour (section 7.1.3)", "name": "SALBUTAMOL - SELECTIVE BETA2 AGONISTS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.1 Bronchodilators", "3.1.1 Adrenoceptor agonists", "3.1.1.1 Selective beta2 agonists", "SALBUTAMOL"], "cautions": "Cautions\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nCautions\u00a0Beta2 agonists should be used with caution in hyperthyroidism, cardiovascular disease, arrhythmias, susceptibility to QT-interval prolongation, and hypertension. Beta2 agonists should be used with caution in diabetes\u2014monitor blood glucose (risk of ketoacidosis, especially when beta2 agonist given intravenously). Interactions: Appendix 1 (sympathomimetics, beta2).Hypokalaemia\u00a0Potentially serious hypokalaemia may result from beta2 agonist therapy. Particular caution is required in severe asthma, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, and diuretics, and by hypoxia. Plasma-potassium concentration should therefore be monitored in severe asthma.", "side-effects": "Side-effects\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nSide-effects\u00a0Side-effects of the beta2 agonists include fine tremor (particularly in the hands), nervous tension, headache, muscle cramps, and palpitation. Other side-effects include tachycardia, arrhythmias, peripheral vasodilation, myocardial ischaemia, and disturbances of sleep and behaviour. Paradoxical bronchospasm (occasionally severe), urticaria, angioedema, hypotension, and collapse have also been reported. High doses of beta2 agonists are associated with hypokalaemia (see Hypokalaemia above).; also lactic acidosis with high\r\ndoses", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/31938.htm", "doses": ["By mouth (but use by inhalation preferred),\r\n4\u00a0mg (elderly and sensitive patients initially 2\u00a0mg) 3\u20134 times daily;\r\nmax. single dose 8\u00a0mg (but unlikely to provide much extra benefit\r\nor to be tolerated); child under 2\r\nyears see BNF for Children; 2\u20136 years 1\u20132\u00a0mg 3\u20134 times daily, 6\u201312 years 2\u00a0mg 3\u20134 times\r\ndaily", "By subcutaneous or intramuscular injection, 500\u00a0micrograms, repeated\r\nevery 4 hours if necessary", "By slow intravenous injection (but\r\nsee also Management of Acute Asthma table), (dilute to a concentration\r\nof 50\u00a0micrograms/mL), 250\u00a0micrograms, repeated if necessary; child under 18 years see BNF for Children", "By intravenous infusion (but see\r\nalso Management of Acute Asthma table), initially 5\u00a0micrograms/minute,\r\nadjusted according to response and heart-rate usually in range 3\u201320\u00a0micrograms/minute,\r\nor more if necessary; child under 18\r\nyears see BNF for Children", "By aerosol inhalation (but see also Management of Acute Asthma table, or Management of Chronic Asthma\r\ntable),\r\n100\u2013200\u00a0micrograms (1\u20132 puffs); for persistent symptoms up to 4 times\r\ndaily; child 100\u00a0micrograms (1 puff),\r\nincreased to 200\u00a0micrograms (2 puffs) if necessary; for persistent\r\nsymptoms up to 4 times daily ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 200\u00a0micrograms\r\n(2 puffs); child 100\u00a0micrograms (1\r\npuff), increased to 200\u00a0micrograms (2 puffs) if necessary", "By inhalation of powder (but see\r\nalso Management of Chronic Asthma\r\ntable),\r\n200\u2013400\u00a0micrograms; for persistent symptoms up to 4 times daily; child over 5 years 200\u00a0micrograms; for persistent\r\nsymptoms up to 4 times daily (for Asmasal Clickhaler\u00ae, Salbulin Novolizer\u00ae, and Ventolin\r\nAccuhaler\u00ae doses, see under preparations) ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 400\u00a0micrograms; child 200\u00a0micrograms", "By inhalation of nebulised solution, adult and child over\r\n5 years 2.5\u20135\u00a0mg, repeated up to 4 times daily or more frequently\r\nin severe cases; child under 5 years\r\n2.5\u00a0mg, repeated up to 4 times daily or more frequently in severe\r\ncases; see also Management of Acute Asthma table and Management of Chronic Asthma\r\ntable"], "pregnancy": "Pregnancy\u00a0see section 3.1"}, {"indications": "Indications\u00a0asthma and other conditions associated\r\nwith reversible airways obstruction; premature labour (section 7.1.3)", "name": "SALBUTAMOL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.1 Bronchodilators", "3.1.1 Adrenoceptor agonists", "3.1.1.1 Selective beta2 agonists", "SALBUTAMOL"], "cautions": "Cautions\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nCautions\u00a0Beta2 agonists should be used with caution in hyperthyroidism, cardiovascular disease, arrhythmias, susceptibility to QT-interval prolongation, and hypertension. Beta2 agonists should be used with caution in diabetes\u2014monitor blood glucose (risk of ketoacidosis, especially when beta2 agonist given intravenously). Interactions: Appendix 1 (sympathomimetics, beta2).Hypokalaemia\u00a0Potentially serious hypokalaemia may result from beta2 agonist therapy. Particular caution is required in severe asthma, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, and diuretics, and by hypoxia. Plasma-potassium concentration should therefore be monitored in severe asthma.", "side-effects": "Side-effects\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nSide-effects\u00a0Side-effects of the beta2 agonists include fine tremor (particularly in the hands), nervous tension, headache, muscle cramps, and palpitation. Other side-effects include tachycardia, arrhythmias, peripheral vasodilation, myocardial ischaemia, and disturbances of sleep and behaviour. Paradoxical bronchospasm (occasionally severe), urticaria, angioedema, hypotension, and collapse have also been reported. High doses of beta2 agonists are associated with hypokalaemia (see Hypokalaemia above).; also lactic acidosis with high\r\ndoses", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/31938.htm", "doses": ["By mouth (but use by inhalation preferred),\r\n4\u00a0mg (elderly and sensitive patients initially 2\u00a0mg) 3\u20134 times daily;\r\nmax. single dose 8\u00a0mg (but unlikely to provide much extra benefit\r\nor to be tolerated); child under 2\r\nyears see BNF for Children; 2\u20136 years 1\u20132\u00a0mg 3\u20134 times daily, 6\u201312 years 2\u00a0mg 3\u20134 times\r\ndaily", "By subcutaneous or intramuscular injection, 500\u00a0micrograms, repeated\r\nevery 4 hours if necessary", "By slow intravenous injection (but\r\nsee also Management of Acute Asthma table), (dilute to a concentration\r\nof 50\u00a0micrograms/mL), 250\u00a0micrograms, repeated if necessary; child under 18 years see BNF for Children", "By intravenous infusion (but see\r\nalso Management of Acute Asthma table), initially 5\u00a0micrograms/minute,\r\nadjusted according to response and heart-rate usually in range 3\u201320\u00a0micrograms/minute,\r\nor more if necessary; child under 18\r\nyears see BNF for Children", "By aerosol inhalation (but see also Management of Acute Asthma table, or Management of Chronic Asthma\r\ntable),\r\n100\u2013200\u00a0micrograms (1\u20132 puffs); for persistent symptoms up to 4 times\r\ndaily; child 100\u00a0micrograms (1 puff),\r\nincreased to 200\u00a0micrograms (2 puffs) if necessary; for persistent\r\nsymptoms up to 4 times daily ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 200\u00a0micrograms\r\n(2 puffs); child 100\u00a0micrograms (1\r\npuff), increased to 200\u00a0micrograms (2 puffs) if necessary", "By inhalation of powder (but see\r\nalso Management of Chronic Asthma\r\ntable),\r\n200\u2013400\u00a0micrograms; for persistent symptoms up to 4 times daily; child over 5 years 200\u00a0micrograms; for persistent\r\nsymptoms up to 4 times daily (for Asmasal Clickhaler\u00ae, Salbulin Novolizer\u00ae, and Ventolin\r\nAccuhaler\u00ae doses, see under preparations) ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 400\u00a0micrograms; child 200\u00a0micrograms", "By inhalation of nebulised solution, adult and child over\r\n5 years 2.5\u20135\u00a0mg, repeated up to 4 times daily or more frequently\r\nin severe cases; child under 5 years\r\n2.5\u00a0mg, repeated up to 4 times daily or more frequently in severe\r\ncases; see also Management of Acute Asthma table and Management of Chronic Asthma\r\ntable"], "pregnancy": "Pregnancy\u00a0see section 3.1"}, {"indications": "Indications\u00a0asthma and other conditions associated\r\nwith reversible airways obstruction; premature labour (section 7.1.3)", "name": "SALBUTAMOL Inhalation", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.1 Bronchodilators", "3.1.1 Adrenoceptor agonists", "3.1.1.1 Selective beta2 agonists", "SALBUTAMOL", "Inhalation"], "cautions": "Cautions\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nCautions\u00a0Beta2 agonists should be used with caution in hyperthyroidism, cardiovascular disease, arrhythmias, susceptibility to QT-interval prolongation, and hypertension. Beta2 agonists should be used with caution in diabetes\u2014monitor blood glucose (risk of ketoacidosis, especially when beta2 agonist given intravenously). Interactions: Appendix 1 (sympathomimetics, beta2).Hypokalaemia\u00a0Potentially serious hypokalaemia may result from beta2 agonist therapy. Particular caution is required in severe asthma, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, and diuretics, and by hypoxia. Plasma-potassium concentration should therefore be monitored in severe asthma.", "side-effects": "Side-effects\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nSide-effects\u00a0Side-effects of the beta2 agonists include fine tremor (particularly in the hands), nervous tension, headache, muscle cramps, and palpitation. Other side-effects include tachycardia, arrhythmias, peripheral vasodilation, myocardial ischaemia, and disturbances of sleep and behaviour. Paradoxical bronchospasm (occasionally severe), urticaria, angioedema, hypotension, and collapse have also been reported. High doses of beta2 agonists are associated with hypokalaemia (see Hypokalaemia above).; also lactic acidosis with high\r\ndoses", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/31917.htm", "doses": ["By mouth (but use by inhalation preferred),\r\n4\u00a0mg (elderly and sensitive patients initially 2\u00a0mg) 3\u20134 times daily;\r\nmax. single dose 8\u00a0mg (but unlikely to provide much extra benefit\r\nor to be tolerated); child under 2\r\nyears see BNF for Children; 2\u20136 years 1\u20132\u00a0mg 3\u20134 times daily, 6\u201312 years 2\u00a0mg 3\u20134 times\r\ndaily", "By subcutaneous or intramuscular injection, 500\u00a0micrograms, repeated\r\nevery 4 hours if necessary", "By slow intravenous injection (but\r\nsee also Management of Acute Asthma table), (dilute to a concentration\r\nof 50\u00a0micrograms/mL), 250\u00a0micrograms, repeated if necessary; child under 18 years see BNF for Children", "By intravenous infusion (but see\r\nalso Management of Acute Asthma table), initially 5\u00a0micrograms/minute,\r\nadjusted according to response and heart-rate usually in range 3\u201320\u00a0micrograms/minute,\r\nor more if necessary; child under 18\r\nyears see BNF for Children", "By aerosol inhalation (but see also Management of Acute Asthma table, or Management of Chronic Asthma\r\ntable),\r\n100\u2013200\u00a0micrograms (1\u20132 puffs); for persistent symptoms up to 4 times\r\ndaily; child 100\u00a0micrograms (1 puff),\r\nincreased to 200\u00a0micrograms (2 puffs) if necessary; for persistent\r\nsymptoms up to 4 times daily ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 200\u00a0micrograms\r\n(2 puffs); child 100\u00a0micrograms (1\r\npuff), increased to 200\u00a0micrograms (2 puffs) if necessary", "By inhalation of powder (but see\r\nalso Management of Chronic Asthma\r\ntable),\r\n200\u2013400\u00a0micrograms; for persistent symptoms up to 4 times daily; child over 5 years 200\u00a0micrograms; for persistent\r\nsymptoms up to 4 times daily (for Asmasal Clickhaler\u00ae, Salbulin Novolizer\u00ae, and Ventolin\r\nAccuhaler\u00ae doses, see under preparations) ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 400\u00a0micrograms; child 200\u00a0micrograms", "By inhalation of nebulised solution, adult and child over\r\n5 years 2.5\u20135\u00a0mg, repeated up to 4 times daily or more frequently\r\nin severe cases; child under 5 years\r\n2.5\u00a0mg, repeated up to 4 times daily or more frequently in severe\r\ncases; see also Management of Acute Asthma table and Management of Chronic Asthma\r\ntable", "Name[Airomir\u00ae (IVAX) ] Aerosol inhalation, salbutamol (as sulphate) 100\u00a0micrograms/metered inhalation, net price 200-dose\r\nunit = \u00a31.97. \r\n    Label:\r\n    Counselling, administration\nAutohaler (breath-actuated aerosol\r\ninhalation), salbutamol (as sulphate) 100\u00a0micrograms/metered\r\ninhalation, net price 200-dose unit = \u00a36.02. \r\n    Label:\r\n    Counselling, administration"], "pregnancy": "Pregnancy\u00a0see section 3.1"}, {"indications": "Indications\u00a0asthma and other conditions associated\r\nwith reversible airways obstruction; premature labour (section 7.1.3)", "name": "SALBUTAMOL Oral", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.1 Bronchodilators", "3.1.1 Adrenoceptor agonists", "3.1.1.1 Selective beta2 agonists", "SALBUTAMOL", "Oral"], "cautions": "Cautions\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nCautions\u00a0Beta2 agonists should be used with caution in hyperthyroidism, cardiovascular disease, arrhythmias, susceptibility to QT-interval prolongation, and hypertension. Beta2 agonists should be used with caution in diabetes\u2014monitor blood glucose (risk of ketoacidosis, especially when beta2 agonist given intravenously). Interactions: Appendix 1 (sympathomimetics, beta2).Hypokalaemia\u00a0Potentially serious hypokalaemia may result from beta2 agonist therapy. Particular caution is required in severe asthma, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, and diuretics, and by hypoxia. Plasma-potassium concentration should therefore be monitored in severe asthma.", "side-effects": "Side-effects\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nSide-effects\u00a0Side-effects of the beta2 agonists include fine tremor (particularly in the hands), nervous tension, headache, muscle cramps, and palpitation. Other side-effects include tachycardia, arrhythmias, peripheral vasodilation, myocardial ischaemia, and disturbances of sleep and behaviour. Paradoxical bronchospasm (occasionally severe), urticaria, angioedema, hypotension, and collapse have also been reported. High doses of beta2 agonists are associated with hypokalaemia (see Hypokalaemia above).; also lactic acidosis with high\r\ndoses", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2881.htm", "doses": ["By mouth (but use by inhalation preferred),\r\n4\u00a0mg (elderly and sensitive patients initially 2\u00a0mg) 3\u20134 times daily;\r\nmax. single dose 8\u00a0mg (but unlikely to provide much extra benefit\r\nor to be tolerated); child under 2\r\nyears see BNF for Children; 2\u20136 years 1\u20132\u00a0mg 3\u20134 times daily, 6\u201312 years 2\u00a0mg 3\u20134 times\r\ndaily", "By subcutaneous or intramuscular injection, 500\u00a0micrograms, repeated\r\nevery 4 hours if necessary", "By slow intravenous injection (but\r\nsee also Management of Acute Asthma table), (dilute to a concentration\r\nof 50\u00a0micrograms/mL), 250\u00a0micrograms, repeated if necessary; child under 18 years see BNF for Children", "By intravenous infusion (but see\r\nalso Management of Acute Asthma table), initially 5\u00a0micrograms/minute,\r\nadjusted according to response and heart-rate usually in range 3\u201320\u00a0micrograms/minute,\r\nor more if necessary; child under 18\r\nyears see BNF for Children", "By aerosol inhalation (but see also Management of Acute Asthma table, or Management of Chronic Asthma\r\ntable),\r\n100\u2013200\u00a0micrograms (1\u20132 puffs); for persistent symptoms up to 4 times\r\ndaily; child 100\u00a0micrograms (1 puff),\r\nincreased to 200\u00a0micrograms (2 puffs) if necessary; for persistent\r\nsymptoms up to 4 times daily ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 200\u00a0micrograms\r\n(2 puffs); child 100\u00a0micrograms (1\r\npuff), increased to 200\u00a0micrograms (2 puffs) if necessary", "By inhalation of powder (but see\r\nalso Management of Chronic Asthma\r\ntable),\r\n200\u2013400\u00a0micrograms; for persistent symptoms up to 4 times daily; child over 5 years 200\u00a0micrograms; for persistent\r\nsymptoms up to 4 times daily (for Asmasal Clickhaler\u00ae, Salbulin Novolizer\u00ae, and Ventolin\r\nAccuhaler\u00ae doses, see under preparations) ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 400\u00a0micrograms; child 200\u00a0micrograms", "By inhalation of nebulised solution, adult and child over\r\n5 years 2.5\u20135\u00a0mg, repeated up to 4 times daily or more frequently\r\nin severe cases; child under 5 years\r\n2.5\u00a0mg, repeated up to 4 times daily or more frequently in severe\r\ncases; see also Management of Acute Asthma table and Management of Chronic Asthma\r\ntable", "Name[Salbutamol (Non-proprietary) ] Tablets, salbutamol (as sulphate) 2\u00a0mg, net price 28-tab pack = \u00a320.60; 4\u00a0mg, 28-tab\r\npack = \u00a319.00\nOral solution, salbutamol (as sulphate) 2\u00a0mg/5\u00a0mL, net price 150\u00a0mL = \u00a31.53Brands include Salapin\u00ae (sugar-free)"], "pregnancy": "Pregnancy\u00a0see section 3.1"}, {"indications": "Indications\u00a0uncomplicated premature labour (\n(From 7.1.3 Myometrial relaxants: British National Formulary)\nA beta2 agonist (salbutamol or terbutaline) is used for inhibiting uncomplicated premature labour between 24 and 33 weeks of gestation and it may permit a delay in delivery of at least 48 hours. Prolonged therapy should be avoided since risk to the mother increases after 48 hours and there is a lack of evidence of benefit from further treatment; maintenance treatment is therefore not recommended.); asthma\r\n(%s\n(From 3.1.1 Adrenoceptor agonists: British National Formulary)\n3.1.1 Adrenoceptor agonists)", "name": "SALBUTAMOL - BETA2 AGONISTS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "7 Obstetrics, gynaecology, and urinary-tract disorders", "7.1 Drugs used in obstetrics", "7.1.3 Myometrial relaxants", "Beta2 agonists"], "cautions": "Cautions\u00a0\n(From Beta2 agonists: British National Formulary)\nCautions\u00a0Beta2 agonists should be used with caution in patients with suspected cardiovascular disease (such patients should be assessed by a cardiologist before initiating therapy\u2014see also Contra-indications, below), hypertension, mild to moderate pre-eclampsia, hyperthyroidism, and hypokalaemia (particular risk with potassium-depleting diuretics\u2014see also Hypokalaemia). It is important to monitor pulse rate (should not exceed 140 beats per minute), ECG (discontinue treatment if signs of myocardial ischaemia develop), and the patient\u2019s fluid and electrolyte status (avoid over-hydration\u2014discontinue drug immediately and initiate diuretic therapy if pulmonary oedema occurs). Beta2 agonists should also be used with caution in diabetes\u2014monitor blood glucose (risk of hyperglycaemia and ketoacidosis, especially with intravenous beta2 agonists).; interactions: Appendix 1 (sympathomimetics, beta2)", "side-effects": "Side-effects\u00a0\n(From Beta2 agonists: British National Formulary)\nSide-effects\u00a0 Side-effects of the beta2 agonists include nausea, vomiting, pulmonary oedema (see Cautions above), palpitation, tachycardia, arrhythmias, myocardial ischaemia, peripheral vasodilation, headache, tremor, hyperglycaemia, hypokalaemia (see Cautions), muscle cramps and tension, and hypersensitivity reactions (including angioedema, urticaria, rash, bronchospasm, hypotension, and collapse).", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4515.htm", "doses": ["By intravenous infusion, initially 10\u00a0micrograms/minute,\r\nrate increased gradually according to response at 10-minute intervals\r\nuntil contractions diminish then increase rate slowly until contractions\r\ncease (max. rate 45\u00a0micrograms/minute); maintain rate for 1\u00a0hour after\r\ncontractions have stopped, then gradually reduce by 50% every 6\u00a0hours;\r\nthen by mouth (but see notes above), 4\u00a0mg every 6\u20138\u00a0hours"]}, {"indications": "Indications\u00a0asthma and other conditions associated\r\nwith reversible airways obstruction; premature labour (section 7.1.3)", "name": "SALBUTAMOL Parenteral", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.1 Bronchodilators", "3.1.1 Adrenoceptor agonists", "3.1.1.1 Selective beta2 agonists", "SALBUTAMOL", "Parenteral"], "cautions": "Cautions\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nCautions\u00a0Beta2 agonists should be used with caution in hyperthyroidism, cardiovascular disease, arrhythmias, susceptibility to QT-interval prolongation, and hypertension. Beta2 agonists should be used with caution in diabetes\u2014monitor blood glucose (risk of ketoacidosis, especially when beta2 agonist given intravenously). Interactions: Appendix 1 (sympathomimetics, beta2).Hypokalaemia\u00a0Potentially serious hypokalaemia may result from beta2 agonist therapy. Particular caution is required in severe asthma, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, and diuretics, and by hypoxia. Plasma-potassium concentration should therefore be monitored in severe asthma.", "side-effects": "Side-effects\u00a0\n(From 3.1.1.1 Selective beta2 agonists: British National Formulary)\nSide-effects\u00a0Side-effects of the beta2 agonists include fine tremor (particularly in the hands), nervous tension, headache, muscle cramps, and palpitation. Other side-effects include tachycardia, arrhythmias, peripheral vasodilation, myocardial ischaemia, and disturbances of sleep and behaviour. Paradoxical bronchospasm (occasionally severe), urticaria, angioedema, hypotension, and collapse have also been reported. High doses of beta2 agonists are associated with hypokalaemia (see Hypokalaemia above).; also lactic acidosis with high\r\ndoses", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2885.htm", "doses": ["By mouth (but use by inhalation preferred),\r\n4\u00a0mg (elderly and sensitive patients initially 2\u00a0mg) 3\u20134 times daily;\r\nmax. single dose 8\u00a0mg (but unlikely to provide much extra benefit\r\nor to be tolerated); child under 2\r\nyears see BNF for Children; 2\u20136 years 1\u20132\u00a0mg 3\u20134 times daily, 6\u201312 years 2\u00a0mg 3\u20134 times\r\ndaily", "By subcutaneous or intramuscular injection, 500\u00a0micrograms, repeated\r\nevery 4 hours if necessary", "By slow intravenous injection (but\r\nsee also Management of Acute Asthma table), (dilute to a concentration\r\nof 50\u00a0micrograms/mL), 250\u00a0micrograms, repeated if necessary; child under 18 years see BNF for Children", "By intravenous infusion (but see\r\nalso Management of Acute Asthma table), initially 5\u00a0micrograms/minute,\r\nadjusted according to response and heart-rate usually in range 3\u201320\u00a0micrograms/minute,\r\nor more if necessary; child under 18\r\nyears see BNF for Children", "By aerosol inhalation (but see also Management of Acute Asthma table, or Management of Chronic Asthma\r\ntable),\r\n100\u2013200\u00a0micrograms (1\u20132 puffs); for persistent symptoms up to 4 times\r\ndaily; child 100\u00a0micrograms (1 puff),\r\nincreased to 200\u00a0micrograms (2 puffs) if necessary; for persistent\r\nsymptoms up to 4 times daily ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 200\u00a0micrograms\r\n(2 puffs); child 100\u00a0micrograms (1\r\npuff), increased to 200\u00a0micrograms (2 puffs) if necessary", "By inhalation of powder (but see\r\nalso Management of Chronic Asthma\r\ntable),\r\n200\u2013400\u00a0micrograms; for persistent symptoms up to 4 times daily; child over 5 years 200\u00a0micrograms; for persistent\r\nsymptoms up to 4 times daily (for Asmasal Clickhaler\u00ae, Salbulin Novolizer\u00ae, and Ventolin\r\nAccuhaler\u00ae doses, see under preparations) ", "Prophylaxis of allergen- or exercise-induced bronchospasm, 400\u00a0micrograms; child 200\u00a0micrograms", "By inhalation of nebulised solution, adult and child over\r\n5 years 2.5\u20135\u00a0mg, repeated up to 4 times daily or more frequently\r\nin severe cases; child under 5 years\r\n2.5\u00a0mg, repeated up to 4 times daily or more frequently in severe\r\ncases; see also Management of Acute Asthma table and Management of Chronic Asthma\r\ntable", "Name[Ventolin\u00ae (A&H) ] Injection, salbutamol (as sulphate) 500\u00a0micrograms/mL, net price 1-mL amp = 38p\nSolution for intravenous infusion, salbutamol (as sulphate) 1\u00a0mg/mL. Dilute before\r\nuse. Net price 5-mL amp = \u00a32.48"], "pregnancy": "Pregnancy\u00a0see section 3.1"}]